JP2025512788A5 - - Google Patents
Info
- Publication number
- JP2025512788A5 JP2025512788A5 JP2024556348A JP2024556348A JP2025512788A5 JP 2025512788 A5 JP2025512788 A5 JP 2025512788A5 JP 2024556348 A JP2024556348 A JP 2024556348A JP 2024556348 A JP2024556348 A JP 2024556348A JP 2025512788 A5 JP2025512788 A5 JP 2025512788A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- acid
- pharmaceutically acceptable
- bioavailability
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2022/083105 | 2022-03-25 | ||
| CN2022083105 | 2022-03-25 | ||
| CN2023079057 | 2023-03-01 | ||
| CNPCT/CN2023/079057 | 2023-03-01 | ||
| PCT/CN2023/083796 WO2023179777A1 (en) | 2022-03-25 | 2023-03-24 | Pharmaceutical compositions of protac compounds and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512788A JP2025512788A (ja) | 2025-04-22 |
| JP2025512788A5 true JP2025512788A5 (https=) | 2026-03-27 |
Family
ID=88100014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556348A Pending JP2025512788A (ja) | 2022-03-25 | 2023-03-24 | Ｐｒｏｔａｃ化合物の医薬組成物及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12350268B2 (https=) |
| EP (1) | EP4499064A4 (https=) |
| JP (1) | JP2025512788A (https=) |
| KR (1) | KR20250004684A (https=) |
| CN (1) | CN119604285A (https=) |
| AU (1) | AU2023239642A1 (https=) |
| CA (1) | CA3246799A1 (https=) |
| MX (1) | MX2024011717A (https=) |
| TW (1) | TW202345842A (https=) |
| WO (1) | WO2023179777A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023003556A (es) | 2020-09-29 | 2023-06-13 | Shenzhen Pharmacin Co Ltd | Composiciones farmaceuticas. |
| IL325099A (en) * | 2023-06-12 | 2026-02-01 | Arvinas Operations Inc | Oral solid estrogen receptor antagonist dosage forms |
| WO2026077844A1 (en) * | 2024-10-07 | 2026-04-16 | Boehringer Ingelheim International Gmbh | Solid dispersions having stabilized emulsion particles |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| OA12625A (en) | 2001-06-22 | 2006-06-12 | Pfizer Prod Inc | Pharmaceutical compositions of adsorbates of amorphous drug. |
| BR0307515A (pt) * | 2002-02-01 | 2004-12-07 | Pfizer Prod Inc | Método para fabricar dispersões de drogas amorfas sólidas secas por aspersão homogêneas usando bicos de pressão |
| DE60320940D1 (de) | 2002-02-01 | 2008-06-26 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien |
| CL2004001884A1 (es) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
| BRPI0413277A (pt) | 2003-08-04 | 2006-10-10 | Pfizer Prod Inc | composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas |
| KR100767349B1 (ko) | 2006-08-01 | 2007-10-17 | 삼천당제약주식회사 | 페노피브레이트를 함유하는 경구용 약제 조성물 및 그의제조방법 |
| WO2013170147A1 (en) * | 2012-05-11 | 2013-11-14 | Yale University | Compounds useful for promoting protein degradation and methods using same |
| KR101770403B1 (ko) | 2016-01-14 | 2017-08-23 | 중앙대학교 산학협력단 | 용해도가 개선된 셀레콕시브 고체분산체 및 이의 제조방법 |
| CN105816437B (zh) | 2016-03-29 | 2018-08-03 | 深圳市药欣生物科技有限公司 | 一种帕布昔利布的药物制剂及其制备方法 |
| CN110506039A (zh) | 2016-10-11 | 2019-11-26 | 阿尔维纳斯股份有限公司 | 用于雄激素受体靶向降解的化合物和方法 |
| BR112019011200B1 (pt) | 2016-12-01 | 2021-12-28 | Arvinas Operations, Inc | Derivados de tetrahidronaftaleno e tetrahidroisoquinolina como degradadores do receptor de estrogênio |
| WO2020121326A1 (en) | 2018-12-13 | 2020-06-18 | Mylan Laboratories Limited | Amorphous (rac)-tramadol.hcl-celecoxib (1:1) |
| US11103502B2 (en) | 2019-01-10 | 2021-08-31 | Slayback Pharma Llc | Pharmaceutical compositions of lurasidone |
| WO2020225738A1 (en) | 2019-05-07 | 2020-11-12 | Alembic Pharmaceuticals Limited | Pharmaceutical composition comprising venetoclax |
| EP3903769A1 (en) | 2020-04-30 | 2021-11-03 | Rheinische Friedrich-Wilhelms-Universität Bonn | Solid and liquisolid formulations of corallopyronin a |
| JP2023540185A (ja) | 2020-09-03 | 2023-09-22 | ニコベンチャーズ トレーディング リミテッド | 組成物及び方法 |
| CN114163444B (zh) * | 2020-09-11 | 2023-07-14 | 江苏恒瑞医药股份有限公司 | 一种用于雄激素受体蛋白靶向降解的嵌合体化合物、其制备方法及其在医药上的应用 |
| CN114181277A (zh) * | 2020-09-15 | 2022-03-15 | 江苏恒瑞医药股份有限公司 | 一种用于雄激素受体蛋白靶向降解的嵌合体化合物、其制备方法及其在医药上的应用 |
| MX2023003556A (es) | 2020-09-29 | 2023-06-13 | Shenzhen Pharmacin Co Ltd | Composiciones farmaceuticas. |
| CN114306245A (zh) | 2020-09-29 | 2022-04-12 | 深圳市药欣生物科技有限公司 | 无定形固体分散体的药物组合物及其制备方法 |
-
2023
- 2023-03-24 AU AU2023239642A patent/AU2023239642A1/en active Pending
- 2023-03-24 TW TW112111149A patent/TW202345842A/zh unknown
- 2023-03-24 CA CA3246799A patent/CA3246799A1/en active Pending
- 2023-03-24 KR KR1020247035233A patent/KR20250004684A/ko active Pending
- 2023-03-24 WO PCT/CN2023/083796 patent/WO2023179777A1/en not_active Ceased
- 2023-03-24 JP JP2024556348A patent/JP2025512788A/ja active Pending
- 2023-03-24 EP EP23774020.4A patent/EP4499064A4/en active Pending
- 2023-03-24 CN CN202380042836.5A patent/CN119604285A/zh active Pending
- 2023-06-28 US US18/343,324 patent/US12350268B2/en active Active
-
2024
- 2024-09-24 MX MX2024011717A patent/MX2024011717A/es unknown
-
2025
- 2025-04-30 US US19/195,162 patent/US20250345327A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025512788A5 (https=) | ||
| AP1227A (en) | Pellets having a core coated with an antifungal and a polymer. | |
| JP6034377B2 (ja) | アリピプラゾール医薬製剤及びその調製方法 | |
| JP2023543815A5 (https=) | ||
| KR101267782B1 (ko) | 이마티닙 메실레이트의 안정화된 무정형 형태 | |
| KR102091295B1 (ko) | 제약 제제 | |
| US6663901B1 (en) | Pellets having a core coated with an antifungal and a polymer | |
| CN102348458A (zh) | 含有6-氟-3-羟基-2-吡嗪甲酰胺的片剂和粒状粉剂 | |
| JP7458440B2 (ja) | 改善された薬物製剤 | |
| HU226580B1 (en) | Pharmaceutical formulation comprising a 2-[[(2-pyridinyl)methyl]sulfinyl] benzimidazole having anti-ulcer activity and a process for the preparation of such formulation | |
| KR20160113294A (ko) | 안드로겐 수용체 길항제의 고체 제약 조성물 | |
| CN107278152A (zh) | 醋酸阿比特龙复合物、其制备方法及包含它们的药物组合物 | |
| JP2023543814A5 (https=) | ||
| ES3055123T3 (en) | Pharmaceutical composition comprising enzalutamide | |
| DE202008018063U1 (de) | Pharmazeutischer Hilfsstoffkomplex | |
| CN1398184A (zh) | 具有改善的生物利用度和缩小的个体内和个体间吸收差异的含有伊曲康唑的组合物 | |
| US20250360085A1 (en) | Improved drug formulations | |
| CN101454003A (zh) | 包含3-[5-[4-(环戊氧基)-2-羟基苯甲酰基]-2-[(3-羟基-1,2-苯并异噁唑-6-基)甲氧基]苯基]丙酸或其盐的口服组合物 | |
| CN101677568A (zh) | 齐拉西酮制剂 | |
| US20160000720A1 (en) | Pharmaceutical compositions comprising Tadalafil | |
| US20180214453A1 (en) | Rivaroxaban pharmaceutical compositions | |
| EP3220894B1 (en) | Nanosuspension formulation | |
| US20120041068A1 (en) | Extended Release Pharmaceutical Preparations for Active Pharmaceutical Ingredients with pH Dependent Solubility | |
| US20110159084A1 (en) | Raloxifene pharmaceutical formulations | |
| US20160081990A1 (en) | Film preparation containing donepezil-free base and method for producing same |